Skip to main content

Heart Disease and the Metabolic Syndrome

  • Chapter
  • First Online:
Book cover Nutrigenomics: How Science Works

Abstract

In this chapter, we will link three important risk factors for heart disease: hypertension, atherosclerosis and dyslipidemia. Chronically elevated blood pressure, i.e., hypertension, increases the risk of ischemic heart disease, stroke, peripheral vascular disease and other CVDs. This is the most important preventable risk factor for premature death. The low intake of fruit and vegetables and whole grain fiber and high consumption of saturated fat and high-cholesterol diets can lead to hypercholesterolemia and atherosclerosis, especially in genetically predisposed individuals. Atherosclerosis is a chronic inflammatory disease caused by the accumulation of cholesterol-laden macrophages in the artery wall, i.e., it is based on dyslipidemia and an overreaction of the immune system. Accordingly, the susceptibility to CVDs is associated with genes affecting the serum levels of plasma lipids and lipoproteins. Furthermore, we will discuss the role of insulin resistance and obesity in the major metabolic tissues liver, skeletal muscle, pancreas and WAT causing the metabolic syndrome. The importance of inflammation and regulation of energy metabolism will be highlighted. The genetic risk for the metabolic syndrome overlaps with that of its major components obesity, T2D and dyslipidemia. However, like in these traits, common genetic variations can explain only a minor part of the disease risk. Therefore, we will present the important role of epigenetics in the origin and development of the metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Additional Readings

  • Barroso I, McCarthy MI (2019) The genetic basis of metabolic disease. Cell 177:146–161

    Article  CAS  Google Scholar 

  • Drummond GR, Vinh A, Guzik TJ, Sobey CG (2019) Immune mechanisms of hypertension. Nat Rev Immunol 19:517–532

    Article  CAS  Google Scholar 

  • Hunter PM, Hegele RA (2017) Functional foods and dietary supplements for the management of dyslipidaemia. Nat Rev Endocrinol 13:278–288

    Article  CAS  Google Scholar 

  • Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ (2014) Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol (11):659–672

    Article  CAS  Google Scholar 

  • Tall AR, Yvan-Charvet L (2015) Cholesterol, inflammation and innate immunity. Nat Rev Immunol 15:104–116

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Carlberg, C., Ulven, S.M., Molnár, F. (2020). Heart Disease and the Metabolic Syndrome. In: Nutrigenomics: How Science Works. Springer, Cham. https://doi.org/10.1007/978-3-030-36948-4_10

Download citation

Publish with us

Policies and ethics